Your search returned 11 results.

Results
	1.	Treatment-related protein biomarker expression differs between primary and recurrent ovarian carcinomas. [electronic resource] by Zajchowski, Deborah A Karlan, Beth Y Shawver, Laura K Producer: 20120618 In: Molecular cancer therapeutics vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Successful use of next generation genomic sequencing (NGS)-directed therapy of clear cell carcinoma of the ovary (CCCO) with trametinib and metformin in a patient with chemotherapy-refractory disease. [electronic resource] by Castro, Michael P Whitcomb, Bradford P Zajchowski, Deborah A Coleman, Robert L Producer: 20160527 In: Gynecologic oncology research and practice vol. 2 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Comprehensive genomic sequencing of paired ovarian cancers reveals discordance in genes that determine clinical trial eligibility. [electronic resource] by Fehniger, Julia E Berger, Amnon A Juckett, Luke Elvin, Julia Levine, Douglas A Zajchowski, Deborah A Producer: 20191219 In: Gynecologic oncology vol. 155 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	The ubiquitin-conjugating enzyme E2-EPF is overexpressed in primary breast cancer and modulates sensitivity to topoisomerase II inhibition. [electronic resource] by Tedesco, Donato Zhang, Jianhuan Trinh, Lan Lalehzadeh, Guita Meisner, Rene Yamaguchi, Ken D Ruderman, Daniel L Dinter, Harald Zajchowski, Deborah A Producer: 20071002 In: Neoplasia (New York, N.Y.) vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Comprehensive genomic profiling reveals inactivating SMARCA4 mutations and low tumor mutational burden in small cell carcinoma of the ovary, hypercalcemic-type. [electronic resource] by Lin, Douglas I Chudnovsky, Yakov Duggan, Bridget Zajchowski, Deborah Greenbowe, Joel Ross, Jeffrey S Gay, Laurie M Ali, Siraj M Elvin, Julia A Producer: 20171128 In: Gynecologic oncology vol. 147 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Anti-tumor efficacy of the nucleoside analog 1-(2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranosyl) cytosine (4'-thio-FAC) in human pancreatic and ovarian tumor xenograft models. [electronic resource] by Zajchowski, Deborah A Biroc, Sandra L Liu, Hsaio-Lai Chesney, Steven K Hoffmann, Jens Bauman, John Kirkland, Thomas Subramanyam, Babu Shen, Jun Ho, Elena Tseng, Jih-Lie Dinter, Harald Producer: 20050516 In: International journal of cancer vol. 114 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Change in Topoisomerase 1-Positive Circulating Tumor Cells Affects Overall Survival in Patients with Advanced Breast Cancer after Treatment with Etirinotecan Pegol. [electronic resource] by Rugo, Hope S Cortes, Javier Awada, Ahmad O'Shaughnessy, Joyce Twelves, Chris Im, Seock-Ah Hannah, Alison Lu, Lin Sy, Sherwin Caygill, Katie Zajchowski, Deborah A Davis, Darren W Tagliaferri, Mary Hoch, Ute Perez, Edith A Producer: 20191220 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 24 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Multiplex gene expression analysis for high-throughput drug discovery: screening and analysis of compounds affecting genes overexpressed in cancer cells. [electronic resource] by Johnson, Paul H Walker, Roger P Jones, Steven W Stephens, Kathy Meurer, Janet Zajchowski, Deborah A Luke, May M Eeckman, Frank Tan, Yuping Wong, Linda Parry, Gordon Morgan, Thomas K McCarrick, Meg A Monforte, Joseph Producer: 20030618 In: Molecular cancer therapeutics vol. 1 Availability: No items available. Save to lists Add to cart (remove)
	9.	The estrogen-responsive B box protein is a novel regulator of the retinoid signal. [electronic resource] by Cheung, Belamy B Bell, Jessica Raif, Anna Bohlken, Andrew Yan, Joanne Roediger, Ben Poljak, Anne Smith, Stewart Lee, Michelle Thomas, Wayne D Kavallaris, Maria Norris, Murray Haber, Michelle Liu, Hsiao-Lai Zajchowski, Deborah Marshall, Glenn M Producer: 20060818 In: The Journal of biological chemistry vol. 281 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Anti-EphA2 antibodies decrease EphA2 protein levels in murine CT26 colorectal and human MDA-231 breast tumors but do not inhibit tumor growth. [electronic resource] by Kiewlich, David Zhang, Jianhuan Gross, Cynthia Xia, Wei Larsen, Brent Cobb, Ronald R Biroc, Sandra Gu, Jian-Ming Sato, Takashi Light, David R Heitner, Tara Willuda, Joerg Vogel, David Monteclaro, Felipe Citkowicz, Andrzej Roffler, Steve R Zajchowski, Deborah A Producer: 20060811 In: Neoplasia (New York, N.Y.) vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Constitutively active ESR1 mutations in gynecologic malignancies and clinical response to estrogen-receptor directed therapies. [electronic resource] by Gaillard, Stéphanie L Andreano, Kaitlyn J Gay, Laurie M Steiner, Meghan Jorgensen, Matthew S Davidson, Brittany Anne Havrilesky, Laura J Alvarez Secord, Angeles Valea, Fidel A Colon-Otero, Gerardo Zajchowski, Deborah A Chang, Ching-Yi McDonnell, Donald P Berchuck, Andrew Elvin, Julia A Producer: 20190826 In: Gynecologic oncology vol. 154 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)